ArticleBlood advances2022

Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis.

Mengyang Di et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.